Skip to main content

Table 5 Biomarkers significant in subpopulation 4, ranked by effect size

From: Case-control Indian buffet process identifies biomarkers of response to Codrituzumab

Continuous Variables

Effect Size

p-value

%Necrotic

2.73

1.86e-04

CD3/CD16 necrotic

2.63

2.85e-04

%Viable

−0.86

1.86e-04

CD3/CD16 viable

−0.85

2.85e-04

  1. Biomarkers significant for subpopulation 4 (subjects with longer PFS in placebo group), compared to subpopulations 1, 2 and 3 (subjects with short PFS in placebo group), ranked by effect size. Biomarkers as in Table 3
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us